Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 59

    Govt expects biotech sector to hit $100 bn by 2025

    Govt expects biotech sector to hit $100 bn by 2025

    supriya kashyap kashyap22 Jan 2017 12:11 PM IST
    New Delhi : The government is targeting the country's biotechnology industry to reach USD 100 billion by 2025, as it works to develop India into a...
    CCI approves Aspen Global-GlaxoSmithKline deal

    CCI approves Aspen Global-GlaxoSmithKline deal

    supriya kashyap kashyap21 Jan 2017 12:32 PM IST
    New Delhi : Competition Commission has cleared Aspen Global's deal to purchase certain drug brands from GlaxoSmithKline.Ultiva, Tracrium, Nimbex,...
    FDA approves a generic of Xyrem to treat Cataplexy and excessive daytime sleepiness

    FDA approves a generic of Xyrem to treat Cataplexy and excessive daytime sleepiness

    supriya kashyap kashyap20 Jan 2017 12:09 PM IST
    The U.S. Food and Drug Administration (FDA) has approved the first generic version of Xyrem (sodium oxybate) Oral Solution, to treat cataplexy and...
    Stent prices to be fixed in 10 to 15 days: Ananth Kumar

    Stent prices to be fixed in 10 to 15 days: Ananth Kumar

    savita thakur thakur20 Jan 2017 11:21 AM IST
    New Delhi: With an aim of providing relief to heart patients, the government said it will fix prices of stents in the next 10-15 days.Chemicals and...
    FIPB clears 6 FDI proposals worth Rs 1,187 crore

    FIPB clears 6 FDI proposals worth Rs 1,187 crore

    supriya kashyap kashyap20 Jan 2017 9:11 AM IST
    New Delhi : Inter-ministerial body FIPB approved six investment proposals, including that of Sanofi Synthelabo India, Star Den Media Services and Idea...
    Shockingly high profit margins on Cardiac stents : NPPA Report

    Shockingly high profit margins on Cardiac stents : NPPA Report

    savita thakur thakur19 Jan 2017 3:45 PM IST
    In the process of fixing prices for cardiac stents including Drug-Eluting Stents (DES) as well as Bare Metal Stent (BMS), the National Pharmaceutical...
    Healthcare tech VC funding in crosses $5bn: Mercom

    Healthcare tech VC funding in crosses $5bn: Mercom

    supriya kashyap kashyap19 Jan 2017 11:38 AM IST
    New Delhi : Venture capital (VC) funding, including private equity as well as corporate, rose to USD 5.1 billion in the healthcare IT sector last...
    Ananth Kumar for simpler tax structure in pharma , chemicals industry

    Ananth Kumar for simpler tax structure in pharma , chemicals industry

    supriya kashyap kashyap17 Jan 2017 11:57 AM IST
    New Delhi : Inverted tax structure in pharma, chemicals and petrochemicals industry needs to be rectified in the upcoming Budget, Chemicals and...
    US Supreme Court agrees to hear dispute over biologic drug sales

    US Supreme Court agrees to hear dispute over biologic drug sales

    supriya kashyap kashyap17 Jan 2017 11:57 AM IST
    New York : The U.S. Supreme Court agreed to hear a dispute over whether companies that make copycat versions of biologic drugs must wait six months...
    Pricing pressure in US to keep pharma companies growth under check

    Pricing pressure in US to keep pharma companies growth under check

    supriya kashyap kashyap16 Jan 2017 10:48 AM IST
    Mumbai : Pharma companies are likely to report sequentially flat EBITDA growth in 3QFY17, impacted by pricing pressure and higher R&D...
    Pharma, biotech stocks topple on Trumps speech

    Pharma, biotech stocks topple on Trump's speech

    supriya kashyap kashyap13 Jan 2017 2:23 PM IST
    New York : Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new...
    Patanjali, state govt to sign MoU for herbal forest project in Haryana

    Patanjali, state govt to sign MoU for herbal forest project in Haryana

    savita thakur thakur9 Jan 2017 11:45 AM IST
    Haryana: Government will soon sign a Memorandum of Understanding (MoU) with yoga guru Ramdev's Patanjali Yogpeeth for the development of a herbal...
    PrevNext

    Popular Stories

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...

    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok